A new poll demonstrates that the vast majority of Americans support the Biden administration’s policy of Medicare negotiating with pharmaceutical companies to lower prescription drug prices.
The Associated Press/NORC poll, conducted from September 7 to 11, asked respondents whether they favored such a program. More than three-quarters (76 percent) said that they do, while only 6 percent said they were outright opposed to the program. Around one in five voters (18 percent) said they did not have an opinion on the matter.
Support for the program, which was passed last year as part of the Inflation Reduction Act, transcended party lines, with 86 percent of Democrats and 66 percent of Republicans voicing support. But when the issue was tied to President Joe Biden, who has long been a supporter of the policy, partisan politics appeared to seep into people’s opinions.
When asked about Biden’s job performance relating to prescription drug costs, 7 in 10 Democrats said they gave him positive marks. But only a quarter of Republicans said they approved of his work on the issue.
The Biden White House has heralded the program as one that will help working class Americans who are struggling to pay for critical prescription medications.
“There is no reason why Americans should be forced to pay more than any developed nation for life-saving prescriptions just to pad Big Pharma’s pockets,” Biden said in a statement last month.
Four of the ten medications that were announced in the initial round of negotiating drug costs are for the treatment of diabetes. The remainder are for treating various other conditions, including heart failure, psoriasis and arthritis, blood cancer and Crohn’s disease. The ten drugs listed account for one in five medications that are part of Medicare Part D prescription costs.
More pharmaceutical drugs subjected to negotiations will be announced in the future, the administration has said.
Per the terms of the law, companies that produce the ten medications will have until the start of next month to decide if they’ll take part in the negotiation process — if they don’t, they’ll be subject to an excise tax equal to 95 percent of their total U.S. drug sales, or they’ll have to opt out of participating in the Medicare and Medicaid programs.
Some pharmaceutical companies have sued the Biden administration over the law, contending that it is in violation of the Constitution. The U.S. Chamber of Commerce is also suing the White House. In total, at least eight lawsuits seek to challenge the law’s requirement to negotiate prices.
Truthout Is Preparing to Meet Trump’s Agenda With Resistance at Every Turn
Dear Truthout Community,
If you feel rage, despondency, confusion and deep fear today, you are not alone. We’re feeling it too. We are heartsick. Facing down Trump’s fascist agenda, we are desperately worried about the most vulnerable people among us, including our loved ones and everyone in the Truthout community, and our minds are racing a million miles a minute to try to map out all that needs to be done.
We must give ourselves space to grieve and feel our fear, feel our rage, and keep in the forefront of our mind the stark truth that millions of real human lives are on the line. And simultaneously, we’ve got to get to work, take stock of our resources, and prepare to throw ourselves full force into the movement.
Journalism is a linchpin of that movement. Even as we are reeling, we’re summoning up all the energy we can to face down what’s coming, because we know that one of the sharpest weapons against fascism is publishing the truth.
There are many terrifying planks to the Trump agenda, and we plan to devote ourselves to reporting thoroughly on each one and, crucially, covering the movements resisting them. We also recognize that Trump is a dire threat to journalism itself, and that we must take this seriously from the outset.
Last week, the four of us sat down to have some hard but necessary conversations about Truthout under a Trump presidency. How would we defend our publication from an avalanche of far right lawsuits that seek to bankrupt us? How would we keep our reporters safe if they need to cover outbreaks of political violence, or if they are targeted by authorities? How will we urgently produce the practical analysis, tools and movement coverage that you need right now — breaking through our normal routines to meet a terrifying moment in ways that best serve you?
It will be a tough, scary four years to produce social justice-driven journalism. We need to deliver news, strategy, liberatory ideas, tools and movement-sparking solutions with a force that we never have had to before. And at the same time, we desperately need to protect our ability to do so.
We know this is such a painful moment and donations may understandably be the last thing on your mind. But we must ask for your support, which is needed in a new and urgent way.
We promise we will kick into an even higher gear to give you truthful news that cuts against the disinformation and vitriol and hate and violence. We promise to publish analyses that will serve the needs of the movements we all rely on to survive the next four years, and even build for the future. We promise to be responsive, to recognize you as members of our community with a vital stake and voice in this work.
Please dig deep if you can, but a donation of any amount will be a truly meaningful and tangible action in this cataclysmic historical moment.
We’re with you. Let’s do all we can to move forward together.
With love, rage, and solidarity,
Maya, Negin, Saima, and Ziggy